Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin

Impacts of peritoneal cancer index on the survival outcomes of patients with colorectal peritoneal carcinomatosis

“…[38] A few recent studies also report a similar 5-year OS for patients with CRPC at their centre. [10,15,16] Our 5-year OS is consistent with their findings. However, our other cohorts (PCI>5) seem to have a shorter 5-year OS as compared to the 5-year OS reported by these studies.…”

Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nationwide study over 14 years

“…In conclusion, the role of CRS associated with HIPEC in children remains debated. Regardless of histology and PCI, the absence of disease outside the abdominal cavity and completeness of cytoreduction are the main prognosis factors in adults and children . In pediatrics, CRS and HIPEC are often considered in palliative situations, when no other treatment is available.…”

S3-Leitlinie – Kolorektales Karzinom

“…Entsprechend kommen für dieses Verfahren nur Patienten mit einer limitierten peritonealen Metastasierung in Betracht. Als Entscheidungshilfe dient der PCI (peritoneal cancer index) [1215]. Rezidive sind nach zytoreduktiver Therapie und intraperitonealer Chemotherapie häufig und gelten als ungünstige prognostische Faktoren [1216].…”